Literature DB >> 7906180

Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery.

H Baumel1, M Huguier, J C Manderscheid, J M Fabre, S Houry, H Fagot.   

Abstract

A multicentre retrospective study was carried out to analyse short- and long-term results of 787 pancreatic resections performed for cancer between 1982 and 1988. The postoperative mortality rate was 10 per cent and the morbidity rate 35 per cent. Age above 70 years and systemic organ failure independently influenced operative mortality. In patients surviving more than 30 days the median survival was 12.3 months and the actuarial survival rate at 5 years 12 per cent. The 5-year survival rate was lower for patients with lymph node involvement than for those without (4 versus 20 per cent, P = 0.001). The operative mortality rate was higher after total pancreatectomy than pancreatoduodenectomy (17 versus 8 per cent, P = 0.015). The median survival time and 5-year survival rate after total pancreatectomy and pancreatoduodenectomy were 11 versus 14 months and 3 versus 15 per cent respectively. Of the clinical and pathological factors studied, location of the tumour in the left pancreas was most strongly related to survival, with no survivors at 4 years. These results suggest that resection should be avoided in patients over 70 years old with systemic organ failure. Pancreatoduodenectomy remains the best procedure for resection, total pancreatectomy being performed only in patients with multifocal carcinoma or those in whom a safe pancreatic anastomosis cannot be constructed.

Entities:  

Mesh:

Year:  1994        PMID: 7906180     DOI: 10.1002/bjs.1800810138

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  50 in total

Review 1.  Adjuvant therapy in pancreatic cancer.

Authors:  P Ghaneh; J Slavin; R Sutton; M Hartley; J P Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Recent advances in the surgical treatment of pancreatic cancer.

Authors:  A Shankar; R C Russell
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 3.  Neoadjuvant, adjuvant, and palliative treatment of pancreatic cancer.

Authors:  D Birk; H G Beger
Journal:  Curr Gastroenterol Rep       Date:  2001-04

4.  Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.

Authors:  W Meyer; C Jurowich; M Reichel; B Steinhäuser; P H Wünsch; C Gebhardt
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  How to pass on expertise: pancreatoduodenectomy at a teaching hospital.

Authors:  Peter Wamser; Anton Stift; Christian Passler; Peter Goetzinger; Thomas Sautner; Raimund Jakesz; Reinhold Fuegger
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

Review 7.  Intraoperative assessment of the Whipple resection specimen.

Authors:  Mahmoud A Khalifa
Journal:  J Clin Pathol       Date:  2007-03-16       Impact factor: 3.411

8.  Anastomotic leakage in pancreatic surgery.

Authors:  Stefano Crippa; Roberto Salvia; Massimo Falconi; Giovanni Butturini; Luca Landoni; Claudio Bassi
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 9.  Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.

Authors:  Markus Schäfer; Beat Müllhaupt; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

10.  Impact of total pancreatectomy: short- and long-term assessment.

Authors:  Louise Barbier; Wisam Jamal; Safi Dokmak; Béatrice Aussilhou; Olivier Corcos; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  HPB (Oxford)       Date:  2013-01-29       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.